ArticleThe Journal of clinical endocrinology and metabolism2020

Objective Response and Prolonged Disease Control of Advanced Adrenocortical Carcinoma with Cabozantinib.

Matthias Kroiss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.